Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envacgen in Children Aged 2 to <10 Years
NCT07178522Phase 3Active, not recruiting
- Sponsor
- Medigen Biotechnology
- Start
- Jun 2025
- Primary completion
- Jul 2026
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of EV71vac in enterovirus 71 infection, sponsored by Medigen Biotechnology. Started Jun 2025; status: active, not recruiting.
02
Drugs
EV71vac
03
Conditions
enterovirus 71 infection
Beyond the preview
Go deeper on NCT07178522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07178522.